These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target. Morabito F; Gentile M; Seymour JF; Polliack A Leuk Lymphoma; 2015; 56(12):3250-6. PubMed ID: 26062943 [TBL] [Abstract][Full Text] [Related]
29. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy. Small S; Ma S Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874 [TBL] [Abstract][Full Text] [Related]
30. Richter syndrome: A rare complication of chronic lymphocytic leukemia or small lymphocytic lymphoma. Wąsik-Szczepanek E; Szymczyk A; Szczepanek D; Wszoła-Kleinrok J; Chocholska S; Pluta A; Hus M Adv Clin Exp Med; 2018 Dec; 27(12):1683-1689. PubMed ID: 30156387 [TBL] [Abstract][Full Text] [Related]
31. Ibrutinib, obinutuzumab, idelalisib, and beyond: review of novel and evolving therapies for chronic lymphocytic leukemia. Chung C; Lee R Pharmacotherapy; 2014 Dec; 34(12):1298-316. PubMed ID: 25355689 [TBL] [Abstract][Full Text] [Related]
32. Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies. Rainone M; Siddiqi T Curr Hematol Malig Rep; 2022 Feb; 17(1):39-45. PubMed ID: 35028825 [TBL] [Abstract][Full Text] [Related]
33. Treatment Patterns, Healthcare Resource Utilization, and Costs of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma in the US. Yang X; Zanardo E; Lejeune D; De Nigris E; Sarpong E; Farooqui M; Laliberté F Oncologist; 2024 Mar; 29(3):e360-e371. PubMed ID: 38280190 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review. Shadman M JAMA; 2023 Mar; 329(11):918-932. PubMed ID: 36943212 [TBL] [Abstract][Full Text] [Related]
35. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. Wierda WG; Byrd JC; Abramson JS; Bilgrami SF; Bociek G; Brander D; Brown J; Chanan-Khan AA; Chavez JC; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lim MS; Ma S; Malek S; Mato A; Mosse C; Shadman M; Siddiqi T; Stephens D; Sundaram S; Wagner N; Dwyer M; Sundar H J Natl Compr Canc Netw; 2020 Feb; 18(2):185-217. PubMed ID: 32023533 [TBL] [Abstract][Full Text] [Related]
36. Novel Therapies for Chronic Lymphocytic Leukemia: A Canadian Perspective. Owen C; Assouline S; Kuruvilla J; Uchida C; Bellingham C; Sehn L Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):627-634.e5. PubMed ID: 26416145 [TBL] [Abstract][Full Text] [Related]
37. State-of-the-Art Treatment and Novel Agents in Chronic Lymphocytic Leukemia. Cramer P; Hallek M; Eichhorst B Oncol Res Treat; 2016; 39(1-2):25-32. PubMed ID: 26890007 [TBL] [Abstract][Full Text] [Related]
38. Idelalisib: a review of its use in chronic lymphocytic leukaemia and indolent non-Hodgkin's lymphoma. Keating GM Target Oncol; 2015 Mar; 10(1):141-51. PubMed ID: 25637459 [TBL] [Abstract][Full Text] [Related]
39. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options. Sharma S; Rai KR Cancer; 2019 May; 125(9):1432-1440. PubMed ID: 30807655 [TBL] [Abstract][Full Text] [Related]
40. Diagnosis and prognosis of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL) and mantle cell lymphoma (MCL). Asaad NY; Abd El-Wahed MM; Dawoud MM J Egypt Natl Canc Inst; 2005 Dec; 17(4):279-90. PubMed ID: 17102815 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]